Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000582522 | SCV000687780 | likely benign | Hereditary cancer-predisposing syndrome | 2016-07-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000628265 | SCV000749160 | likely benign | Ataxia-telangiectasia syndrome | 2023-08-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000582522 | SCV002669672 | likely benign | Hereditary cancer-predisposing syndrome | 2017-09-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV004568288 | SCV005050781 | likely benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | ATM: BP4, BP7 |
Myriad Genetics, |
RCV004592880 | SCV005082615 | benign | Familial cancer of breast | 2024-06-14 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |